Stock search

Ticker or company name

ABT card

ABT price forecast

Abbott Laboratories$107,45

P/E now is 39,9. Average over 5 years: 28,2 (range 23–35). The stock is 42% above its history.

Base · FY2030

$174,62+14,8% a year

The base case gives 14,8% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$46,6 bn$48,9 bn$51,4 bn$54,0 bn$56,8 bn
Net income$8,69 bn$9,13 bn$9,59 bn$10,1 bn$10,6 bn
EPS$4,99$5,27$5,56$5,86$6,19

Changed values are highlighted. Bear and bull cases: growth ∓ 11,9%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $107,45

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$68,56

Price change
−36,2%
A year
−7,6%
Fair value today
$52,34
Margin of safety
−51,3%

Base$174,62

Price change
+62,5%
A year
+14,8%
Fair value today
$128,11
Margin of safety
+19,2%

Bull$403,72

Price change
+275,7%
A year
+39,9%
Fair value today
$289,17
Margin of safety
+169,1%

What growth the price implies

For the stock to return 10% a year, revenue must grow 3,1% a year to FY2030 at a 18,6% margin and P/E 28,2.

Growth over 5 years
5,1%
Analyst consensus
no data
In your model
5,1%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$174,62+14,8% a year